GlassScriptPhysician profile
Andrew Slaton
NPI 1912453937
$2,865.32
in general payments reported to CMS, 2019-2025
14 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $523 · 2023: $840 · 2024: $240 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,698.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $522.58 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $514.55 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $374.39 | 2021-2025 | Spravato |
| Axsome Therapeutics, INC. | $351.89 | 2023-2025 | Auvelity |
| Abbvie INC. | $327.95 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $172.73 | 2022-2025 | Ingrezza |
| Eisai INC. | $138.94 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $111.30 | 2023 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $109.96 | 2024 | Cobenfy |
| Vanda Pharmaceuticals INC. | $106.23 | 2025 | Fanapt |
| Hologic Sales and Service, LLC | $52.72 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Lundbeck LLC | $43.14 | 2022-2023 | Rexulti |
| Exact Sciences Corporation | $21.94 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $17.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Slaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.